- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
![Methyl 1-[(2'-cyanobiphenyl-4-yl) methyl]-2-ethoxy-1H-benzimidazole-7-carboxylatum](/upload/6698/methyl-1-2-cyanobiphenyl-4-yl-methyl-2-ethoxy-1h-benzimidazole-7-carboxylate_71844.gif "Methyl 1-[(2'-cyanobiphenyl-4-yl) methyl]-2-ethoxy-1H-benzimidazole-7-carboxylatum")
Methyl 1-[(2'-cyanobiphenyl-4-yl) methyl]-2-ethoxy-1H-benzimidazole-7-carboxylatum
Product Name:Methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylatum
Formulae hypotheticae: C25H21N3O3
Molecular pondus:411.45
CAS Registry Number: 139481-44-0
![Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole] -7-Carboxylatum](/upload/6698/ethyl-2-ethoxy-1-2-cyanobiphenyl-4-yl-methyl-benzimidazole-7-carboxylate_281423.gif "Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole] -7-Carboxylatum")
Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole] -7-Carboxylatum
Product Name: Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole] -7-Carboxylatum
Formulae hypotheticae: C26H23N3O3
Molecular pondus:425.48
CAS Registry Number: 139481-41-7
![D-Glucitol, 1,5-anhydro-I-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S)- (9CI)](/upload/6698/d-glucitol-1-5-anhydro-1-c-3-5-4-fluorophenyl-2-thienyl-methyl-4-methylphenyl-tetraacetate-1s-9ci-_23979.gif "D-Glucitol, 1,5-anhydro-I-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S)- (9CI)")
D-Glucitol, 1,5-anhydro-I-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S)- (9CI)
Product Name:D-Glucitolum, 1,5-anhydro-I-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetum, (1S)- ( 9CI)
Formulae hypotheticae: C32H33FO9S
Molecular pondus:612,66
CAS Registry Number: 866607-35-4
DL-SERINE HYDRAZIDE HYDROCHLORIDE
Product Name: DL-SERINE HYDRAZIDE HYDROCHLORIDE
Formulae hypotheticae: C3H10ClN3O2
Molecular pondus:155.5834
CAS Registry Number: 55819-71-1
2,3,4-Trihydroxybenzaldehyde
Product Name:2,3,4-Trihydroxybenzaldehyde
Formulae hypotheticae: C7H6O4
Molecular pondus:154.12
CAS Subcriptio Number:2144-08-3
![1-(4-Methoxyphenyl) -7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine -3-acidi carboxylici ethyl ester](/upload/6698/1-4-methoxyphenyl-7-oxo-6-4-2-oxopiperidin-1-yl-phenyl-4-5-6-7-tetrahydro-1h-pyrazolo-3-4-c-pyridine-3-carboxylic-acid-ethyl-ester_968529.gif "1-(4-Methoxyphenyl) -7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine -3-acidi carboxylici ethyl ester")
1-(4-Methoxyphenyl) -7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine -3-acidi carboxylici ethyl ester
Product Name:1-(4-Methoxyphenyl) -7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4- c] acidum pyridine-3-carboxylicum ethyl ester
Formulae hypotheticae: C27H28N4O5
Molecular pondus:488.54
CAS Subcriptio Number:503614-91-3
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
